NCT00902785View on ClinicalTrials.gov

A Study Of Early Markers Of Choroidal Neovascularization

TerminatedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Choroidal Neovascularization (CNV)Age-related Macular Degeneration (AMD)Early Markers
Interventions
OTHER

no drug

observational no drug

Trial Locations (3)

20157

Pfizer Investigational Site, Milan

3000-354

Pfizer Investigational Site, Coimbra

BT12 6BA

Pfizer Investigational Site, Belfast

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY